InsiderClue
← All stocks

CG Oncology, Inc.

CGON Net buying
CIK 0001991792 #1141 in the set updated 17 Sep 2026
Bought (120 mo)
$87.48M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$53.15M
$2.78M on a plan · $7.77M straight out of an exercise
Sold at will
$42.60M
3 of 42 sales
Net
+$34.33M
+$44.88M against sales at will

By person

8 insiders · 50 transactions
Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
Liu Brian Guan-Chyun
Director
$74.81M (2)
—
+$74.81M
1,886,236
2.13%
$140.60M
—
Song Hong Fang
Director
$5.00M (1)
$45.38M (7)
−$40.38M
3,517,859
3.97%
$262.22M
—
Decheng Capital Global Life Sciences Fund IV, L.P. entity
10% owner
$7.60M (1)
—
+$7.60M
4,958,812
5.59%
$369.63M
+432.9%
Mulay James
Director
—
$6.28M (16) scheduled
−$6.28M
0
0.0000%
$0.00
—
POST LEONARD E
Director
—
$1.49M (19) scheduled
−$1.49M
0
0.0000%
$0.00
—
Roche Corleen M.
CFO
$38.00K (1)
—
+$38.00K
2,000
0.0023%
$149.08K
—
Kasturi Vijay
Chief Medical Officer
$24.99K (1)
—
+$24.99K
1,315
0.0015%
$98.02K
—
Kuan Arthur
Chief Executive Officer
—
—
—
198,916
0.2244%
$14.83M
+450.2%

Individual transactions

50
Insider
Date
Role
Action
Shares
Price
Amount
POST LEONARD E
14 Aug 2026
Director
Sold after exercise
1,000
$74.54
$74.54K
POST LEONARD E
15 Jul 2026
Director
Sold after exercise
1,000
$71.17
$71.17K
Mulay James
10 Jul 2026
Director
Sold after exercise
24,165
$75.16
$1.82M
Liu Brian Guan-Chyun
25 Jun 2026
Director
Buy indirect
371,085
$66.87
$24.81M
POST LEONARD E
24 Jun 2026
Director
Sold after exercise
5,000
$70.00
$350.00K
POST LEONARD E
22 Jun 2026
Director
Sold after exercise
5,000
$65.00
$325.00K
Mulay James
15 Jun 2026
Director
Sold after exercise
1,310
$60.12
$78.76K
Mulay James
15 Jun 2026
Director
Sold after exercise
654
$60.12
$39.32K
POST LEONARD E
4 Jun 2026
Director
Sold after exercise
1,000
$54.50
$54.50K
Mulay James
17 Apr 2026
Director
Sold after exercise
15,600
$73.01
$1.14M
Mulay James
16 Mar 2026
Director
Sold after exercise
1,310
$63.50
$83.19K
Mulay James
16 Mar 2026
Director
Sold after exercise
654
$63.50
$41.53K
Kuan Arthur
12 Mar 2026
Chief Executive Officer
Exercised, kept
64,612
$1.72
$111.13K
Kuan Arthur
4 Mar 2026
Chief Executive Officer
Exercised, kept
102,871
$1.72
$176.94K
Mulay James
9 Jan 2026
Director
Sold after exercise
10,491
$52.99
$555.92K
Mulay James
9 Jan 2026
Director
Sold after exercise
654
$44.16
$28.88K
POST LEONARD E
17 Nov 2025
Director
Sold after exercise
1,000
$41.43
$41.43K
POST LEONARD E
13 Oct 2025
Director
Sold after exercise
1,000
$43.25
$43.25K
Mulay James
9 Oct 2025
Director
Sold after exercise
5,903
$43.99
$259.67K
POST LEONARD E
30 Sep 2025
Director
Sold after exercise
5,000
$40.09
$200.45K
Mulay James
29 Sep 2025
Director
Sold after exercise
12,755
$39.19
$499.87K
Mulay James
19 Sep 2025
Director
Sold after exercise
3,574
$38.99
$139.35K
Mulay James
18 Sep 2025
Director
Sold after exercise
19,112
$39.01
$745.56K
POST LEONARD E
15 Sep 2025
Director
Sold after exercise
1,000
$35.10
$35.10K
Liu Brian Guan-Chyun
11 Sep 2025
Director
Buy indirect
1,515,151
$33.00
$50.00M
Mulay James
5 Sep 2025
Director
Sold after exercise
3,113
$33.22
$103.41K
Mulay James
5 Sep 2025
Director
Sold after exercise
7,465
$32.64
$243.66K
Mulay James
5 Sep 2025
Director
Sold after exercise
4,095
$31.42
$128.66K
Mulay James
5 Sep 2025
Director
Sold after exercise
12,342
$30.47
$376.06K
POST LEONARD E
3 Sep 2025
Director
Sold after exercise
1,000
$28.00
$28.00K
Song Hong Fang
3 Sep 2025
Director
Sold on a plan indirect
100
$28.99
$2.90K
Song Hong Fang
3 Sep 2025
Director
Sold on a plan indirect
100
$28.96
$2.90K
Song Hong Fang
3 Sep 2025
Director
Sold on a plan indirect
30,105
$28.24
$850.17K
Song Hong Fang
3 Sep 2025
Director
Sold on a plan indirect
69,695
$27.60
$1.92M
POST LEONARD E
17 Jul 2025
Director
Sold after exercise
2,000
$28.00
$56.00K
POST LEONARD E
21 May 2025
Director
Sold after exercise
1,000
$28.00
$28.00K
POST LEONARD E
28 Apr 2025
Director
Sold after exercise
1,000
$30.76
$30.76K
POST LEONARD E
17 Mar 2025
Director
Sold after exercise
1,000
$28.00
$28.00K
POST LEONARD E
18 Feb 2025
Director
Sold after exercise
1,000
$28.61
$28.61K
POST LEONARD E
13 Jan 2025
Director
Sold after exercise
1,000
$29.66
$29.66K
POST LEONARD E
16 Dec 2024
Director
Sold after exercise
1,000
$28.84
$28.84K
Song Hong Fang
16 Dec 2024
Director
Sell indirect
700,000
$28.00
$19.60M
POST LEONARD E
6 Dec 2024
Director
Sold after exercise
250
$34.98
$8.74K
POST LEONARD E
6 Dec 2024
Director
Sold after exercise
750
$34.40
$25.80K
Song Hong Fang
29 Aug 2024
Director
Sell indirect
226,245
$35.36
$8.00M
Song Hong Fang
29 Aug 2024
Director
Sell indirect
424,210
$35.36
$15.00M
Decheng Capital Global Life Sciences Fund IV, L.P.
29 Jan 2024
10% owner
Buy indirect
400,000
$19.00
$7.60M
Song Hong Fang
29 Jan 2024
Director
Buy
263,157
$19.00
$5.00M
Roche Corleen M.
29 Jan 2024
CFO & Secretary
Buy
2,000
$19.00
$38.00K
Kasturi Vijay
29 Jan 2024
Chief Medical Officer
Buy
1,315
$19.00
$24.99K

What was left out

Form 4 filings counted 73
Amendments (4/A) skipped 1
Filings about a different issuer 0
Unreadable filings 0
Joint filings 1
Sales on a Rule 10b5-1 plan 4
Sales straight out of an exercise 35
Sales at will 3
Transactions with no price 0
Shares from compensation/vesting 9,246,735
History held since 26 Jan 2024